Imunon, Inc. (IMNN)
NASDAQ · Healthcare
Imunon, Inc. Shareholder Equity 2017–2022
Imunon, Inc. annual shareholder equity history from 2017 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Imunon, Inc. shareholder equity as of December 31, 2022: 29.3M, a 47.44% decrease year-over-year.
- Imunon, Inc. shareholder equity for 2022 were 29.3M, a 47.44% decrease from 2021.
- Imunon, Inc. shareholder equity for 2021 were 55.8M, a 199.80% increase from 2020.
- Imunon, Inc. shareholder equity for 2020 were 18.6M, a 27.83% increase from 2019.
- Imunon, Inc. shareholder equity for 2019 were 14.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Imunon, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $29 |
| 2021 | $56 |
| 2020 | $19 |
| 2019 | $15 |
| 2018 | $21 |
| 2017 | $27 |
Imunon, Inc. Shareholder Equity — FAQ
Imunon, Inc. (IMNN) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNN's shareholder equity history?
The chart and table above show Imunon, Inc.'s shareholder equity by year and by quarter, including the growth rate.